Everyone loves the backup quarterback because they’ve never played a down. But once those backups play, the sports analogy goes, and they are almost always worse than the starter. Are digital health VCs the backup quarterbacks of healthcare investing? Rightfully, there’s a lot of excitement about corporate venture’s increasing prominence in healthcare. But don’t get […]
Part II in our research examining which corporate venture capitalists you can trust and rely on.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
If you run a startup, do these three rules resonate?
When that potential first big customer drops in your lap, how do you make the most of it? For an early-stage healthcare company, it’s about balancing the time commitment against the actual ROI, said Jean-Luc Neptune (@jeanlucneptune), executive director at Blueprint Health (@bphealth). Neptune is one of four speakers who’ll discuss the challenges of modern […]
Hard truth: Even the most promising startups are one calamity away from completely shutting down. Self-inflicted wounds are hard to escape from. But there are increasingly a number of options when a competitor, customer or would-be investor puts a company on the brink. Lee Ducker, one of the founders of Lake Whillans, sees the horror […]
Hey startup CEO: How will you need to think differently about protecting your assets in a way that allows you to build value in the long term?
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
There are plenty of good investors out there, but many will pull a Mr. Hyde act to get what they want from healthcare entrepreneurs.
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.
We all want the 12x, but what happens when you're the 1x - and how do you make sure nothing goes wrong?
Through litigation finance, CFOs can manage a dormant asset: potential litigation.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Last week, I discussed the changing landscape of medtech innovation, and how shifting dynamics in the capital raising process have led young businesses to be more vulnerable to unscrupulous partners and mal-intentioned competitors. This week I will begin discussing how distressed venture funding and litigation finance can be used to help protect these innovating young […]
Unfortunately, it is not uncommon for larger corporations to invest in promising healthcare companies, only to take advantage of their position by developing the underlying technology themselves or dispensing with the project so as to avoid cannibalizing sales.
Read this in-the-trenches view of fund-raising for life science companies. How has the landscape changed? And how can you better protect yourself as you start talking about your proprietary ideas to grant committee and big corporations? Find out who an entrepreneur's biggest ally is when they are doing healthcare fund-raising.
Distressed venture finance and litigation finance are relatively new financial products that can help otherwise vulnerable businesses protect themselves. Companies, such as Lake Whillans, that provide these products can help businesses threatened by others' unscrupulous actions.
How can healthcare entrepreneurs protect their intellectual property in a cost-effective way? An experienced entrepreneur offers his top tips.